Mark McLaughlin
Chief of Staff
Mark brings over 20 years immunology and inflammation, product & portfolio strategy experience, spanning early to late-stage development, product launch and life-cycle management. Prior to Navigator, he served as Vice President, Marketing, leading product launches for two consecutive biotechs, CymaBay and ChemoCentryx, resulting in exists to Gilead and Amgen.
Mark has held positions of increasing responsibility at AstraZeneca and AbbVie, where he led global launch strategy for FASENRA® in severe asthma, and multiple indication launches for HUMIRA® in rheumatology, dermatology, and gastroenterology.
Mark holds of Bachelor’s in Science degree from Manchester Metropolitan University & a Post-Graduate Diploma in Marketing from the Chartered Institute of Marketing.
